tiprankstipranks
Trending News
More News >
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market

Zenas BioPharma, Inc. (ZBIO) Income Statement

Compare
157 Followers

Zenas BioPharma, Inc. Income Statement

Last quarter (Q3 2025), Zenas BioPharma, Inc.'s total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Zenas BioPharma, Inc.'s net income was $-51.50M. See Zenas BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 5.00M$ 50.00M$ 0.00
Gross Profit
$ -134.14M$ 50.00M$ -61.69M
Operating Expenses
$ 29.75M$ 87.15M$ 14.51M
Depreciation and Amortization
$ 137.00K$ 113.00K$ 78.00K
EBITDA
$ -163.75M$ -27.03M$ -75.12M
Operating Income
$ -163.89M$ -37.15M$ -76.20M
Other Income/Expenses
$ 7.33M$ 324.00K$ -43.08M
Pretax Income
$ -156.56M$ -36.82M$ -119.28M
Net Income
$ -156.99M$ -37.12M$ -119.28M
Per Share Metrics
Basic EPS
$ -3.76$ -0.97$ -3.11
Diluted EPS
$ -3.76$ -0.97$ -3.11
Weighted Average Shares Outstanding
41.79M 38.32M 38.32M
Weighted Average Shares Outstanding (Diluted)
41.79M 38.32M 38.32M
Currency in USD

Zenas BioPharma, Inc. Earnings and Revenue History